DISCONTINUED OPERATIONS - Narrative (Details) - USD ($) $ in Millions			1 Months Ended	9 Months Ended	12 Months Ended
	Jan. 31, 2025	Sep. 29, 2023	May 31, 2023	Sep. 30, 2025	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net book value		$ 840
Other comprehensive income					$ 126	$ 183	$ 68
Manufacturing and supply agreement, period			5 years
Indemnification Agreement
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnification liability, net					53
Contingent liability for qualifying capital expenditures					$ 133
Contingent liability, term					3 years
Contingent liability					$ 83
Business guarantees retained					35
Kidney Care Manufacturing and Supply Agreement
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Transaction service agreement, period	10 years
Kidney Care Transition Services Agreement
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Transaction service agreement, period	30 months
Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on subsidiary liquidation				$ 97	97	0	2,882
Discontinued Operations, Disposed of by Sale | BioPharma Solutions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Agreed purchase price		4,250
Proceeds from divestiture of businesses		3,910
Pre-tax gain on sale		2,880
Net proceeds of sale		2,590
Loss on subsidiary liquidation					0	0	2,882
Pre-tax cash proceeds		3,960
Transaction costs		47
Other comprehensive income		$ 181
Separation costs							17
Discontinued Operations, Disposed of by Sale | Kidney Care
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Agreed purchase price	$ 3,800
Proceeds from divestiture of businesses	3,710
Pre-tax gain on sale	191
Net proceeds of sale	$ 111
Loss on subsidiary liquidation					97	0	0
Separation costs					$ 37	$ 261	$ 196